Primary sclerosing cholangitis cost-effectiveness of therapy: Difference between revisions
No edit summary |
Irfan Dotani (talk | contribs) No edit summary |
||
Line 2: | Line 2: | ||
{{Primary sclerosing cholangitis}} | {{Primary sclerosing cholangitis}} | ||
{{CMG}}; {{AE}} | |||
==Overview== | |||
==Cost Effectiveness of Therapy== | |||
==References== | ==References== | ||
{{reflist|2}} | |||
[[Category:Hepatology]] | |||
[[Category:Gastroenterology]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} |
Latest revision as of 17:57, 15 July 2016
Primary sclerosing cholangitis Microchapters |
Differentiating Primary sclerosing cholangitis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Primary sclerosing cholangitis cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Primary sclerosing cholangitis cost-effectiveness of therapy |
FDA on Primary sclerosing cholangitis cost-effectiveness of therapy |
CDC on Primary sclerosing cholangitis cost-effectiveness of therapy |
Primary sclerosing cholangitis cost-effectiveness of therapy in the news |
Blogs on Primary sclerosing cholangitis cost-effectiveness of therapy |
Directions to Hospitals Treating Primary sclerosing cholangitis |
Risk calculators and risk factors for Primary sclerosing cholangitis cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: